SpyGlass Pharma, Inc.

US$36.95As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SGPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$1.236B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$40
7.29%
(68.13%)
Hold 9|2|12|6|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.37
0.36
0.38
0.37
16.12%
11.54%
9.40%
(1.25%)
Revenue$M
162.6
168.6
164.2
173.6
4.22%
5.83%
3.71%
5.78%
Peers (US$1.236B)
Cap (US$)
PE
1.227B
—
1.225B
10.77x
1.221B
0.652x
Capital
TTM
5Y
10Y
Leveragex
8.392
(0.090)
(0.041)
EBIT/Intx
0.524
0.199
0.234
Own earn%
140.92
(11.40)
(12.07)
Sh yield%
14.56
27.31
27.62
Owners
Insiders/Inst%
13.21
81.44
Short interest%
3.25
SBC / revenue%
2.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
8–18
$1 testx
—
Incr. ROIC%
2